Oral Rinse May Detect Early-Stage Cancer

Oral Rinse May Detect Early-Stage Cancer March 9, 2015 The OncAlert oral cancer risk assessment system from Vigilant Biosciences Inc, Miami, is based on patented technology and designed to detect specific protein markers known to indicate an elevated risk for oral cancer, even before symptoms are observed. Noninvasive and easy to administer, the procedure requires

How a Miami Life Science Firm Grew from a Son’s Mission to Fight Oral Cancer

How a Miami Life Science Firm Grew from a Son’s Mission to Fight Oral Cancer February 25, 2015 Entrepreneur Matthew H.J. Kim wished his mother’s oral cancer had been caught earlier. He struggled to watch her go through treatments for the disease, including the removal of part of her jawbone. There had to be a

Vigilant Raises $5.5M in Funding

Vigilant Raises $5.5M in Funding February 25, 2015 Vigilant Biosciences has raised $5.5 million in Series B funding. The company intends to use the newly raised funds to get U.S. and European approval for its oral cancer device, the OncAlert oral cancer risk assessment system. The OncAlert system detects specific protein markers known to indicate

Miami Life Science Startup Stems from Personal Mission to Fight Oral Cancer

Miami Life Science Startup Stems from Personal Mission to Fight Oral Cancer February 24, 2015 Matthew H.J. Kim, a patent attorney by training, was heart-broken by the suffering and aggressive treatment his mother went through with oral cancer. He also saw first-hand the results of what he calls an inadequate standard of care resulting in

Miami Startup Raises $5.5M for Cancer Risk Detection System

Miami Startup Raises $5.5M for Cancer Risk Detection System February 24, 2015 Miami-based Vigilant Biosciences raised $5.5 million to launch its oral cancer risk detection system, the firm announced Tuesday. Investors included White Owl Capital Partners, venVelo and the Florida Institute for the Commercialization of Public Research. The company has raised $7.8 million to date.

Vigiliant Marks Milestone Certification

Vigiliant Marks Milestone Certification December 11, 2014 Vigilant Biosciences has received International Organization for Standardization (ISO) 13485:2003 certification, an internationally recognized quality standard for medical devices. The certification covers the design, development, production, sales, and service of Vigilant’s OncAlert oral cancer-specific risk assessment products. This certification demonstrates that Vigilant has successfully implemented a quality management

State Universities Should Be Drivers of Tomorrow’s ‘Innovation Economy’

State Universities Should Be Drivers of Tomorrow’s ‘Innovation Economy’ June 26, 2017 After witnessing the effects of oral cancer on his parents, Matthew Kim knew he wanted to do something to spare others from the pain and disfigurement associated with this potentially life-threatening disease. His mother endured multiple surgeries and treatments, ultimately beating the disease

University of Miami Scientists Are Developing a ‘Rinse and Spit’ Test for Oral Cancers

University of Miami Scientists Are Developing a ‘Rinse and Spit’ Test for Oral Cancers May 23, 2014 After working for more than 10 years on the problem, scientists from the University of Miami are getting ready to roll out a cheap, fast and easy test for detecting oral cancers early — even before anything visible

Rinse-and-Spit Test Kit Company Gets $2.3M to Develop an Early Oral Cancer Screening

Rinse-and-Spit Test Kit Company Gets $2.3M to Develop an Early Oral Cancer Screening March 26, 2014 Oral cancers don’t get a lot of mainstream attention because they aren’t among the deadliest cancers by sheer numbers. They do, however, carry a surprisingly high mortality rate: between 40 and 50 percent of people diagnosed with an oral cancer die

Licensing Office Helps Physician and Entrepreneur Bring Oral Cancer Test to Patients

Licensing Office Helps Physician and Entrepreneur Bring Oral Cancer Test to Patients May 1, 2012 One day in the not so distant future, many of the 50,000 Americans destined to be diagnosed with head and neck cancer annually, as well as millions at risk, could learn with a simple gargle-and-spit test that they could develop

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev2